In a group of 56 COVID-19 patients, although 45 patients were positive for LAC, anti-cardiolipin or anti-B2-GP1, IgG and IgM were detected in only 5/45 patients (10%) (41). This evidence concerns the gene GTPBP1 and COVID-19.